Skip to main content
Caplight Logo









AI4Eyes

AI4Eyes

Private
MontrealHealthcare & Life Scienceshttps://www.aiforeyes.com/en

Last Round

Grant

Jul 7, 2026

Total Funding Raised

$9.37M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AI4Eyes is a healthtech company that develops an AI-powered platform integrating clinical-grade imaging, diagnosis, and treatment recommendations for eye health providers.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Medical Imaging, Workflow Automation

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

ocular surface diseaseOSDsoftware as a medical deviceSaMDdry eye diagnosismedical imagingclinical workflow automationophthalmology softwareAI diagnosticseye care technologymedtechdiagnostic hardwaredigital healthpay-per-test

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AI4Eyes Comparables

Compare AI4Eyes with similar companies based on industry and business-model similarity.

AI4Eyes comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CSI Dry Eye Innovations
84%
SBM Sistemi
79%
E-Swin
79%

AI4Eyes Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 7, 2026
Internal RoundDec 31, 2025
GrantDec 1, 2025
Early FundingDec 1, 2025
GrantOct 1, 2025

Key People

Founding team and executive leadership

Tara Akhavan

Chief Executive Officer

Executive Team

Tal Tuchman

Fractional CFO

Executive Team

AI4Eyes Investors

Notable investors and investment history

AI4Eyes investors
InvestorRounds
MEDTEQ+Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 7, 2026

    Secured $490K from MEDTEQ+ and government

  • Oct 1, 2025

    Secured $4.65M in grant funding.

Recent news

Latest coverage and updates

  • launchesJul 8, 2026

    Aiforeyes launches AI-powered dry eye disease diagnosis and treatment recommendation platform.

AI4Eyes Filings

Explore SEC and related filing metadata, where available.

AI4Eyes filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AI4Eyes's valuation, stock price, and market status.

Is AI4Eyes a public or private company?

AI4Eyes is a private company.

What is the current stock price of AI4Eyes?

AI4Eyes is a private company with no public stock price. No recent secondary market data is available.

How much is AI4Eyes worth (valuation)?

Valuation information for AI4Eyes is not publicly available.

Can I buy AI4Eyes stock?

AI4Eyes shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AI4Eyes's last funding round?

AI4Eyes's most recent funding round was Internal Round on January 12, 2026.

Who are the main investors in AI4Eyes?

Investor information for AI4Eyes is not publicly disclosed.

Will AI4Eyes IPO soon?

No public IPO plans have been announced for AI4Eyes.

How can I track AI4Eyes secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AI4Eyes's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontreal
Employee Range5
Year Founded2020
Last FundingJul 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?